Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves-Jean Bignon

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Journal International De Bioethique Et D'Ethique Des Sciences|July 1, 2016
[SELECTED ETHICAL ISSUES IN ONCOGENETICS]Yves-Jean Bignon
Journal International De Bioethique = International Journal of Bioethics|December 8, 2015
[Selected ethical issues in oncogenetics]Yves-Jean Bignon
La Revue Du Praticien|December 5, 2018
CarcinogenesisMathias Cavaillé, Yves-Jean Bignon
La Revue Du Praticien|December 5, 2018
Cancer: carcinogenesis, oncogeneticMathias Cavaillé, Yves-Jean Bignon
International Journal of Oncology|March 15, 2002
Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell lineValerie Sylvain, Stephane Lafarge, Yves-Jean Bignon
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Rad50 c.687delT does not contribute significantly to familial breast cancer in a French populationNancy Uhrhammer, Laetitia Delort, Yves-Jean Bignon
Breast Cancer Research : BCR|November 26, 2011
CHEK2 contribution to hereditary breast cancer in non-BRCA familiesAlexis Desrichard, Yannick Bidet, Nancy Uhrhammer, et al.
Bulletin Du Cancer|February 1, 2015
[Informing the family: emotions and attitudes of oncogenetic counselees for familial breast/ovarian and/or colon cancer risk]Fabrice Kwiatkowski, Claire Laquet, Pascal Dessenne, et al.
Nutrition and Cancer|July 26, 2003
Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell linesCécile Vissac-Sabatier, Yves-Jean Bignon, Dominique J Bernard-Gallon
Oncology Reports|June 18, 2002
Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinomaRaymonda Varon, Sandrine Gosse-Brun, Yves-Jean Bignon, et al.
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Journal International De Bioethique Et D'Ethique Des Sciences|July 1, 2016
[SELECTED ETHICAL ISSUES IN ONCOGENETICS]Yves-Jean Bignon
Journal International De Bioethique = International Journal of Bioethics|December 8, 2015
[Selected ethical issues in oncogenetics]Yves-Jean Bignon
La Revue Du Praticien|December 5, 2018
CarcinogenesisMathias Cavaillé, Yves-Jean Bignon
La Revue Du Praticien|December 5, 2018
Cancer: carcinogenesis, oncogeneticMathias Cavaillé, Yves-Jean Bignon
International Journal of Oncology|March 15, 2002
Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell lineValerie Sylvain, Stephane Lafarge, Yves-Jean Bignon
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Rad50 c.687delT does not contribute significantly to familial breast cancer in a French populationNancy Uhrhammer, Laetitia Delort, Yves-Jean Bignon
Breast Cancer Research : BCR|November 26, 2011
CHEK2 contribution to hereditary breast cancer in non-BRCA familiesAlexis Desrichard, Yannick Bidet, Nancy Uhrhammer, et al.
Bulletin Du Cancer|February 1, 2015
[Informing the family: emotions and attitudes of oncogenetic counselees for familial breast/ovarian and/or colon cancer risk]Fabrice Kwiatkowski, Claire Laquet, Pascal Dessenne, et al.
Nutrition and Cancer|July 26, 2003
Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell linesCécile Vissac-Sabatier, Yves-Jean Bignon, Dominique J Bernard-Gallon
Oncology Reports|June 18, 2002
Nijmegen breakage syndrome gene (NBS1) is not the tumor suppressor gene at 8q21.3 involved in colorectal carcinomaRaymonda Varon, Sandrine Gosse-Brun, Yves-Jean Bignon, et al.
Pageof 20